A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Radiologic progression and correlation of Genant and Larsen scores
収録刊行物
-
- Arthritis & Rheum
-
Arthritis & Rheum 43 1001-1009, 2000